February 6, 2015

McKesson on Thursday reported that revenues for the third quarter ended Dec. 31, 2014 totaled $47 billion, up 37% compared to $34.3 billion a year ago.

January 5, 2015

McKesson on Monday released its 2014 Corporate Citizenship Report, an annual publication highlighting the company’s commitment to corporate social responsibility.

December 10, 2014

McKesson announced that it has launched McKesson Ventures, a strategic venture capital fund.

 

December 2, 2014

McKesson on Tuesday announced that the Stuttgart Higher Regional Court approved the registration of the domination and profit and loss transfer agreement between Celesio and McKesson Deutschland.

November 24, 2014

Omnicare and McKesson on Monday announced the signing of an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. 

October 29, 2014

McKesson reported that revenues for the second quarter ended Sept. 30 were $44.8 billion, up 36% compared with the year-ago period.  

 

July 30, 2014

McKesson on Wednesday announced preliminary voting results from its annual meeting of stockholders, held earlier today in Redwood City, Calif.

June 23, 2014

McKesson on Monday announced Lori Schechter has been appointed EVP, general counsel and chief compliance officer, replacing Laureen Seeger, who will leave McKesson at the end of June to become the EVP and general counsel of American Express Company.

May 13, 2014

McKesson reported that revenues for the fourth quarter ended March 31 were $38.1 billion, up 25%.

March 6, 2014

McKesson on Wednesday announced that its board of directors has elected Anthony Coles as a new independent director, effective April 29, 2014.

February 18, 2014

McKesson and Rite Aid on Tuesday announced the signing of an expanded distribution agreement to include both brand and generic pharmaceuticals.

January 31, 2014

Days following the acquisition of a majority stake in Celesio, McKesson Corp. reported that revenues for the third quarter ended Dec. 31 totaled $34.3 billion, up 10% compared with a year ago.

January 31, 2014

If you don't succeed the first time, try, try again. That's exactly what McKesson did when it announced that it reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares. And in a separate and subsequent agreement, McKesson also picked up the Celesio convertible bonds from Elliott.

Nothing good is ever easy. "While the path to securing this acquisition was certainly not what we had originally expected, it would seem that the interested parties to this transaction continued to see the compelling strategic benefit of McKesson and Celesio uniting to form a global leader in health care services," John Hammergren, McKesson chairman, CEO and president, said of the deal. "I never lost sight of the value this transaction will bring to our customers, our supply chain partners, the employees of both organizations and our shareholders."

January 24, 2014

McKesson announced that it has reached an agreement with Franz Haniel & Cie. GmbH to acquire its entire holding of Celesio shares for 23.50 euros per share (US $32.24 per share).

January 14, 2014

McKesson may take another bite of the Celesio apple, suggested Sterne Agee analyst Greg Bolan in a note published Monday.

January 13, 2014

McKesson on Monday announced that it was unsuccessful in reaching the 75% completion condition in its offer for the outstanding shares and convertible bonds of Celesio.

October 24, 2013

McKesson on Thursday reported $33 billion in revenues for the second quarter ended Sept. 30, up 11% compared to the year-ago period.

October 24, 2013

McKesson on Thursday confirmed its proposed acquisition of Celesio, a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors, with an agreement to acquire a majority stake in Celesio for €23 per share (US$31.75 per share) and to launch parallel voluntary public tender offers for the remaining publicly traded shares and outstanding convertible bonds of Celesio.

October 1, 2013

McKesson on Monday announced James Beer will join the company as EVP and CFO on Oct. 9. Beer will be responsible for overseeing all financial functions for McKesson and replaces Jeff Campbell, who left the company in June 2013 to become CFO of American Express Co.

July 31, 2013

McKesson on Wednesday announced preliminary voting results from its annual meeting of stockholders.

July 25, 2013

Distribution Solutions revenues were up 5% in the first quarter, driven mainly by strong growth in U.S. pharmaceutical direct distribution and services revenues and the acquisition of PSS World Medical. Technology Solutions revenues were up 9% in the first quarter compared to the prior year.

June 21, 2013

McKesson has announced that Jeffrey C. Campbell, EVP and CFO, will leave the company at the end of June to become the CFO of American Express.

May 8, 2013

McKesson on Tuesday reported fiscal year revenues of $122.5 billion, relatively flat as compared with the prior fiscal year.

March 5, 2013

A number of pharma companies joined Monday on the launch of the CommonWell Health Alliance to better enable seamless access to healthcare data.